Searched for
SANOFI VACCINE BRANDS
Dr Reddy's to introduce Sanofi's novel drug in IndiaDr. Reddy's Laboratories has expanded its partnership with Sanofi Healthcare to introduce Beyfortus, a novel drug preventing lower respirat...- Sweet Surrender: Sanofi puts star insulin brand Lantus up for sale, eyes Rs 2,000 cr from Indian pharma giantsSanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licens...
- Over 250 medicines to cost more from January 1 in the U.S; is your critical drug in the list? Check hereMore than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning January 1, 2025.
- Polio vaccine shortage looms over India with Sanofi plants' shutdownAn impending crisis looms over India's supply of injectable poliomyelitis vaccine (IPV) as French drugmaker Sanofi has shut down its manufa...
- Dr Reddy's to promote, distribute Sanofi vaccine brands in IndiaThe announcement comes a day after Sanofi Healthcare India announced a separate partnership with Cipla to boost access to Sanofi's central ...
- Sanofi says it's back to the drawing board on mRNA flu vaccinesSanofi, one of the top global vaccine makers, has stated that the current mRNA technology used in COVID-19 vaccines is not effective agains...
- Sanofi board approves demerger of its consumer healthcare businessThis decision will open new gates for the India business and employees in a value-driven move to accelerate growth for both the pharmaceuti...
- French drugmaker Sanofi looks to spin off its consumer business in IndiaThe leading vaccine maker is working with Bank of America on the demerger process, said the people cited above. About 60% of Sanofi India i...
- Will PLI help Indian pharma gain market share at cost of MNCs?Indian pharmaceutical companies are becoming more aggressive and increasing their market share and capex. Companies such as Divis, Dr Reddy...
- Are companies bribing doctors to push vaccine combos?Paediatricians question these huge price increases with the addition of just one more vaccine.
- N Rajaram on how Sanofi plans to be in pink of health in India“PM’s Ayushman Bharat policy will give an opportunity for various players in healthcare sector to grow.”
- Sanofi bets on India with portfolio of drugs for diabetes, rare diseasesSanofi reported one of the sharpest falls in its global sales in the fourth quarter, owing to the decline in diabetes drug sales, a controv...
- Regulatory actions won't stop growth of emerging markets, says Sanofi EVPEmerging markets account for 7% of Sanofi’s global revenues, driven by its limited product in rare diseases, diabetes and oncology segments.
- Sanofi, Boehringer Ingelheim seek CCI nod for $25-billion global asset swap dealThe commission will review if the two companies swapping their businesses will cause any adverse impact on the local competition.
- Government may exempt Sanofi’s dengue vaccine from large-scale clinical trialsIf cleared, the step may eventually pave the way for Dengvaxia's availability via the wide government distribution system and private chann...
- French drug-maker Sanofi to buy animal health division of Dosch PharmaceuticalsFrench drug-maker Sanofi has entered into an agreement to acquire the animal health division of Indian firm Dosch Pharmaceuticals for an un...
- Sanofi charts India-specific strategy to boost shareFrench drug maker Sanofi says it is considering an India-specific strategy to increase its share in the country’s Rs 65,000-crore drug mark...
- Sanofi Aventis plans to buy Generics, OTC brandsIt was also believed to been in the fray to buy Actis' 63% stake in Paras Pharmaceuticals, that was eventually acquired by Reckitt Benckise...
- Sanofi to acquire Chattem, expand presence in USSanofi-aventis agreed to buy Chattem, the maker of Gold Bond medicated body powder, for $1.9 billion to enter the US consumer health care m...
- Novartis-Aventis row leads to shortage of anti-rabies vaccineBeware of Dogs! There is a shortage of anti-rabies vaccine in the country, thanks to a dispute between Novartis and Sanofi Aventis, which t...
Load More
